Overview

Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the efficacy of olanzapine in the treatment of manic or mixed symptoms associated with bipolar I disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Haloperidol
Haloperidol decanoate
Olanzapine